NASDAQ:MLYS

Mineralys Therapeutics Stock Forecast

etoro logo Buy MLYS
*Your capital is at risk
$23.62
-0.320 (-1.34%)
At Close: Jun 12, 2026
AI Analysis AI Analysis of MLYS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add MLYS to Watchlist?
Some Reasons Why To Add MLYS:
  • Low bankruptcy risk (Altman Z-Score: 63.18)
  • Bullish trend confirmed on both short and long timeframes
  • +64.9% price growth over the last year
PDF

Mineralys Therapeutics, Inc. stock upgraded from Sell Candidate to Hold/Accumulate after Friday trading session
(Updated on Jun 12, 2026)

Hold candidate since Jun 12, 2026

The Mineralys Therapeutics, Inc. stock price fell by -1.34% on the last day (Friday, 12th Jun 2026) from $23.94 to $23.62. During the last trading day the stock fluctuated 4.04% from a day low at $23.26 to a day high of $24.20. The price has fallen in 8 of the last 10 days and is down by -25.02% for this period. Volume has increased on the last day by 314 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $42.47 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $22.62 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 6.34% during the next 3 months and, with a 90% probability hold a price between $24.05 and $33.89 at the end of this 3-month period.

MLYS Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 4.98%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Mineralys Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $23.82 and $27.60. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Mineralys Therapeutics, Inc. stock

Mineralys Therapeutics, Inc. finds support from accumulated volume at $23.51 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.94 between high and low, or 4.04%. For the last week, the stock has had daily average volatility of 5.06%.

Our recommended stop-loss: $22.71 (-3.87%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 4 days ago.)

Trading Expectations (MLYS) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Mineralys Therapeutics, Inc. to open at $23.69, and during the day (based on 14 day Average True Range), to move between $22.80 and $24.44, which gives a possible trading interval of +/-$1.64 (+/-7.19%) up or down from last closing price. If Mineralys Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.19% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $23.69 (0.30%) than the support at $23.51 (0.47%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Mineralys Therapeutics, Inc. stock A Buy?

Mineralys Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.990 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $23.69 ( 0.310%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

MLYS Performance

Trading levels for MLYS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 24.63 4.29%
R2 24.27 2.77%
R1 24.05 1.83%
Price 23.62
S1 23.33 -1.21%
S2 23.11 -2.15%
S3 22.75 -3.67%

Accumulated Volume Support & Resistance Levels

Level Price
R3 28.43 20.36%
R2 25.06 6.10%
R1 23.69 0.296%
Price 23.62
S1 23.51 -0.466%
S2 23.28 -1.44%
S3 22.50 -4.74%

FAQ

What is the symbol for Mineralys Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Mineralys Therapeutics, Inc. is MLYS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Mineralys Therapeutics, Inc. Stock?
Mineralys Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Mineralys Therapeutics, Inc. Stock?
Mineralys Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Mineralys Therapeutics, Inc. Stock.

What's the current price of Mineralys Therapeutics, Inc. Stock?
As of the end of day on the Jun 12, 2026, the price of an Mineralys Therapeutics, Inc. (MLYS) share was $23.62.

What is the 52-week high and low for Mineralys Therapeutics, Inc. Stock?
The 52-week high for Mineralys Therapeutics, Inc. Stock is $47.65 and the 52-week low is $12.59.

What is the market capitalization of Mineralys Therapeutics, Inc. Stock?
As of the Jun 12, 2026, the market capitalization of Mineralys Therapeutics, Inc. is 1.566B.

When is the next earnings date for Mineralys Therapeutics, Inc.?
The upcoming earnings date for Mineralys Therapeutics, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE